Chunling Wan
Overview
Explore the profile of Chunling Wan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
1365
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Gao Y, Hu X, Wang D, Jiang J, Li M, Qing Y, et al.
Nutrients
. 2023 Mar;
15(5).
PMID: 36904193
Polyunsaturated fatty acids (PUFAs), especially long-chain PUFAs (LCPUFAs), are crucial for both the structural and functional integrity of cells. PUFAs have been reported to be insufficient in schizophrenia, and the...
12.
Zhang T, Zeng J, Ye J, Gao Y, Hu Y, Xu L, et al.
Transl Psychiatry
. 2023 Jan;
13(1):9.
PMID: 36631451
Immunological/inflammatory factors are implicated in the development of psychosis. Complement is a key driver of inflammation; however, it remains unknown which factor is better at predicting the onset of psychosis....
13.
Wang J, Qing Y, Liang J, Cui G, Wang Q, Zhang J, et al.
J Affect Disord
. 2022 Dec;
324:69-76.
PMID: 36521667
Background: Depressive disorder (DD) affects approximately 20 % of adolescents worldwide, but it is underdiagnosed due to the lack of objective biomarkers. Niacin skin flushing response (NSFR) is an objective...
14.
Qing Y, Liang J, Wang J, Wan C, Ke X
Schizophr Res
. 2022 Aug;
248:32-34.
PMID: 35933741
Mental disorders are the leading cause of disability in children and adolescents worldwide, but among the difficulties that pediatric mental health faces is a lack of objective biomarkers used for...
15.
Li M, Gao Y, Wang D, Hu X, Jiang J, Qing Y, et al.
Schizophr Bull
. 2022 Jun;
48(5):1125-1135.
PMID: 35751100
Background And Hypothesis: Multiple lines of clinical, biochemical, and genetic evidence suggest that disturbances of membrane lipids and their metabolism are probably involved in the etiology of schizophrenia (SCZ). Lipids...
16.
Li J, Shu A, Sun Y, Yang W, Tang X, Pu H, et al.
Neurobiol Aging
. 2022 Mar;
113:1-6.
PMID: 35247757
Spinocerebellar ataxia type 3 (SCA3), also known as Machado Joseph disease (MJD), is a common dominantly inherited ataxia, and has heterogeneous clinical features and variable age of onset, ranging from...
17.
Qing Y, Xu L, Cui G, Sun L, Hu X, Yang X, et al.
NPJ Schizophr
. 2021 Oct;
7(1):51.
PMID: 34711862
Schizophrenia is a debilitating mental disorder and often has a prodromal period, referred to as clinical high risk (CHR) for psychosis, prior to the first episode. The etiology and pathogenesis...
18.
Shen L, Lv X, Huang H, Li M, Huai C, Wu X, et al.
EBioMedicine
. 2021 Oct;
72:103609.
PMID: 34628353
Background: Schizophrenia (SCZ) is a severe psychiatric disorder that affects approximately 0.75% of the global population. Both genetic and environmental factors contribute to development of SCZ. SCZ tends to run...
19.
Cui G, Qing Y, Li M, Sun L, Zhang J, Feng L, et al.
J Proteome Res
. 2021 Oct;
20(11):5010-5023.
PMID: 34618462
Schizophrenia is a complex and highly heterogeneous mental illness with a prodromal period called clinical high risk (CHR) for psychosis before onset. Metabolomics is greatly promising in analyzing the pathology...
20.
Wu X, Huai C, Shen L, Li M, Yang C, Zhang J, et al.
iScience
. 2021 Aug;
24(8):102894.
PMID: 34401673
Schizophrenia (SCZ) is a severe neuropsychiatric disorder that affects 1% of the global population. Copy number variations (CNVs) have been shown to play a critical role in its pathophysiology; however,...